A Study Comparing Two Subcutaneous Formulations: Vial and Autoinjector (AI) With Olezarsen, at Two Dose Levels, in Healthy Adult Participants
Clinical trial NCT05579860 · COMPLETED
Trial details
- NCT number
- NCT05579860
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-05
- Primary completion
- 2023-05-22
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.